Published in Women's Health Weekly, July 17th, 1995
The inventor, Professor Jean-Marc Alche of th Faculte de Pharmacie, at the University of Clermont-Ferrand, France, an authority on bioadhesive delivery systems, has applied this new technology to buccal (cheek), vaginal, nasal and rectally delivered products.
When drugs and hormones are given orally, they are often inactivated after ingestion by the liver; this is known as the first liver pass effect. This new technology facilitates the process of developing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly